Reported 0 shares, down 57,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
32 managers reported BIOMARIN PHARMACEUTICAL INC for Q4 2020.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Reduced | 0 | -1,690,000 | 0 | $0 | 16 qtrs |
| GLAZER CAPITAL LLC | Unchanged | 0 | 0 | 0 | $0 | 2 qtrs |
| Daiwa Securities Group Inc | Reduced | 0 | -1,000,000 | 0 | $0 | 2 qtrs |
| Sowell Financial Services LLC This report | Reduced | 0 | -57,000 | 0 | $0 | 6 qtrs |
| D E Shaw & Co Inc | Reduced | 0 | -60,985,000 | 0 | $0 | 3 qtrs |
| TENOR CAPITAL MANAGEMENT Co L P | Reduced | 0 | -29,597,000 | 0 | $0 | 2 qtrs |
| BLUEFIN CAPITAL MANAGEMENT LLC | Reduced | 0 | -52,500 | 0 | $0 | 2 qtrs |
| EDMOND DE ROTHSCHILD HOLDING S A | Reduced | 0 | -2,606,000 | 0 | $0 | 10 qtrs |
| PALISADE CAPITAL MANAGEMENT LLC NJ | Reduced | 0 | -1,359,000 | 0 | $0 | 29 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -3 | 0 | $0 | 4 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2020
- Filed
- January 13, 2021
- Filing type
- 13F-HR
- Position type
- Convertible
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.